LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 54

Search options

  1. Article ; Online: Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection.

    Dewaele, Klaas / Claeys, Rowan

    Blood

    2020  Volume 135, Issue 25, Page(s) 2323

    MeSH term(s) Anemia/etiology ; Bone Marrow/pathology ; COVID-19 ; Coronavirus Infections/complications ; Female ; Ferritins/blood ; Hemoglobins/analysis ; Humans ; Lymphohistiocytosis, Hemophagocytic/blood ; Lymphohistiocytosis, Hemophagocytic/etiology ; Lymphohistiocytosis, Hemophagocytic/pathology ; Macrophages/ultrastructure ; Middle Aged ; Pandemics ; Phagocytosis ; Pneumonia, Viral/complications
    Chemical Substances Hemoglobins ; Ferritins (9007-73-2)
    Keywords covid19
    Language English
    Publishing date 2020-06-18
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood.2020006505
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: SARS-CoV-2 Infection–Associated Hemophagocytic Lymphohistiocytosis

    Prilutskiy, Andrey / Kritselis, Michael / Shevtsov, Artem / Yambayev, Ilyas / Vadlamudi, Charitha / Zhao, Qing / Kataria, Yachana / Sarosiek, Shayna R / Lerner, Adam / Sloan, J Mark / Quillen, Karen / Burks, Eric J

    American Journal of Clinical Pathology

    2020  Volume 154, Issue 4, Page(s) 466–474

    Abstract: ... of hemophagocytic lymphohistiocytosis (HLH) have not been reported. We studied the reticuloendothelial organs of 4 consecutive patients ... with a partial H-score of 145 due to a missing triglyceride level. The remaining 2 patients had H-scores of 131 ... and 96. Conclusions This is the first report of severe acute respiratory syndrome coronavirus 2 ...

    Abstract Abstract Objectives A subset of coronavirus disease 2019 (COVID-19) patients exhibit clinical features of cytokine storm. However, clinicopathologic features diagnostic of hemophagocytic lymphohistiocytosis (HLH) have not been reported. We studied the reticuloendothelial organs of 4 consecutive patients who died of COVID-19 and correlated with clinical and laboratory parameters to detect HLH. Methods Autopsies were performed on 4 patients who died of COVID-19. Routine H&E staining and immunohistochemical staining for CD163 were performed to detect hemophagocytosis. Clinical and laboratory results from premortem blood samples were used to calculate H-scores. Results All 4 cases demonstrated diffuse alveolar damage within the lungs. Three of the 4 cases had histologic evidence of hemophagocytosis within pulmonary lymph nodes. One case showed hemophagocytosis in the spleen but none showed hemophagocytosis in liver or bone marrow. Lymphophagocytosis was the predominant form of hemophagocytosis observed. One patient showed diagnostic features of HLH with an H-score of 217, while a second patient likely had HLH with a partial H-score of 145 due to a missing triglyceride level. The remaining 2 patients had H-scores of 131 and 96. Conclusions This is the first report of severe acute respiratory syndrome coronavirus 2–associated HLH. Identification of HLH in a subset of patients with severe COVID-19 will inform clinical trials of therapeutic strategies.
    Keywords General Medicine ; covid19
    Language English
    Publisher Oxford University Press (OUP)
    Publishing country uk
    Document type Article ; Online
    ZDB-ID 2944-0
    ISSN 1943-7722 ; 0002-9173
    ISSN (online) 1943-7722
    ISSN 0002-9173
    DOI 10.1093/ajcp/aqaa124
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Secondary Hemophagocytic Lymphohistiocytosis in a Neonate with SARS-CoV-2 Infection.

    El-Isa, Hasan Zuhair / Khader, Osama As'ad / Khader, Mustafa / Ashour, Bahaa Abed / Azzam, Muayad Imad / Badran, Eman Farouk

    The American journal of case reports

    2022  Volume 23, Page(s) e934839

    Abstract: ... that leads to multi-organ failure. CASE REPORT We describe a case of a female newborn, born to a SARS-CoV-2 ... positive mother via cesarean section delivery at 35 weeks of gestation, that tested positive for SARS-CoV-2 ... symptoms than adults when infected with SARS-CoV-2, for reasons not well understood, although multiple ...

    Abstract BACKGROUND Infants born to mothers with Coronavirus disease (COVID-19) are susceptible to infection, either vertically or horizontally. The mechanism is not completely understood. Regardless, it is rare that an infant with COVID-19 suffers from serious, life-threatening complications. We speculate that one of these complications can be hemophagocytic lymphohistiocytosis (HLH), a dysregulated hyperinflammatory response that leads to multi-organ failure. CASE REPORT We describe a case of a female newborn, born to a SARS-CoV-2-positive mother via cesarean section delivery at 35 weeks of gestation, that tested positive for SARS-CoV-2 on the first day after birth. The patient presented with progressive respiratory distress, intermittent fever, splenomegaly, and cytopenia. Hemophagocytic lymphohistiocytosis (HLH) work-up was done, which showed hyperferritinemia, hypofibrinogenemia, and hypertriglyceridemia. Bone marrow aspirate showed hemophagocytic activity of both red blood cells and platelets. We suspect that the virus triggered HLH, which led to the patient's death at 51 days of age due to severe respiratory failure. CONCLUSIONS Infants and children suffer from milder symptoms than adults when infected with SARS-CoV-2, for reasons not well understood, although multiple hypotheses have been proposed, which are discussed in this paper. However, there is a possibility that the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) virus can cause HLH and multi-system inflammatory syndrome in children (MIS-C).
    MeSH term(s) COVID-19/complications ; Cesarean Section ; Female ; Humans ; Infant, Newborn ; Lymphohistiocytosis, Hemophagocytic/diagnosis ; Lymphohistiocytosis, Hemophagocytic/etiology ; Pregnancy ; Pregnancy Complications, Infectious ; SARS-CoV-2 ; Systemic Inflammatory Response Syndrome
    Language English
    Publishing date 2022-01-28
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 2517183-5
    ISSN 1941-5923 ; 1941-5923
    ISSN (online) 1941-5923
    ISSN 1941-5923
    DOI 10.12659/AJCR.934839
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Ruxolitinib as an Effective Treatment for Hemophagocytic Lymphohistiocytosis Secondary to SARS-Cov-2 Infection: A Case Report.

    Wang, Lina / Zhang, Xiaolin / Huang, Bo / Hou, Yue / Liu, Xinmin / Jiao, Hongmei

    Infection and drug resistance

    2023  Volume 16, Page(s) 2467–2473

    Abstract: ... syndrome. SARS-CoV-2 infection can induce secondary HLH, as described in previous case reports ... with HLH related to previous SARS-CoV-2 infection. Fever was the only clinical manifestation initially ... should be aware of the possibility of HLH secondary to mild SARS-CoV-2 infection and take timely therapeutic ...

    Abstract Background: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome. SARS-CoV-2 infection can induce secondary HLH, as described in previous case reports, but diagnosis and treatment are challenging.
    Case study: We described an older male patient diagnosed with HLH related to previous SARS-CoV-2 infection. Fever was the only clinical manifestation initially but deterioration in clinical condition and laboratory parameters was observed during hospitalization. He responded poorly to classical therapy but was successfully treated with ruxolitinib.
    Conclusion: Clinicians should be aware of the possibility of HLH secondary to mild SARS-CoV-2 infection and take timely therapeutic measures to inhibit an inflammatory factor storm. Ruxolitinib is a potential choice for COVID-19 related HLH.
    Language English
    Publishing date 2023-04-26
    Publishing country New Zealand
    Document type Case Reports
    ZDB-ID 2494856-1
    ISSN 1178-6973
    ISSN 1178-6973
    DOI 10.2147/IDR.S384035
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.

    Prilutskiy, Andrey / Kritselis, Michael / Shevtsov, Artem / Yambayev, Ilyas / Vadlamudi, Charitha / Zhao, Qing / Kataria, Yachana / Sarosiek, Shayna R / Lerner, Adam / Sloan, J Mark / Quillen, Karen / Burks, Eric J

    American journal of clinical pathology

    2020  Volume 154, Issue 4, Page(s) 466–474

    Abstract: ... of cytokine storm. However, clinicopathologic features diagnostic of hemophagocytic lymphohistiocytosis (HLH ... with a partial H-score of 145 due to a missing triglyceride level. The remaining 2 patients had H-scores of 131 ... and 96.: Conclusions: This is the first report of severe acute respiratory syndrome coronavirus 2 ...

    Abstract Objectives: A subset of coronavirus disease 2019 (COVID-19) patients exhibit clinical features of cytokine storm. However, clinicopathologic features diagnostic of hemophagocytic lymphohistiocytosis (HLH) have not been reported. We studied the reticuloendothelial organs of 4 consecutive patients who died of COVID-19 and correlated with clinical and laboratory parameters to detect HLH.
    Methods: Autopsies were performed on 4 patients who died of COVID-19. Routine H&E staining and immunohistochemical staining for CD163 were performed to detect hemophagocytosis. Clinical and laboratory results from premortem blood samples were used to calculate H-scores.
    Results: All 4 cases demonstrated diffuse alveolar damage within the lungs. Three of the 4 cases had histologic evidence of hemophagocytosis within pulmonary lymph nodes. One case showed hemophagocytosis in the spleen but none showed hemophagocytosis in liver or bone marrow. Lymphophagocytosis was the predominant form of hemophagocytosis observed. One patient showed diagnostic features of HLH with an H-score of 217, while a second patient likely had HLH with a partial H-score of 145 due to a missing triglyceride level. The remaining 2 patients had H-scores of 131 and 96.
    Conclusions: This is the first report of severe acute respiratory syndrome coronavirus 2-associated HLH. Identification of HLH in a subset of patients with severe COVID-19 will inform clinical trials of therapeutic strategies.
    MeSH term(s) Aged ; Aged, 80 and over ; Autopsy ; Betacoronavirus ; Bone Marrow/pathology ; COVID-19 ; Coronavirus Infections/complications ; Coronavirus Infections/diagnosis ; Coronavirus Infections/pathology ; Fatal Outcome ; Female ; Humans ; Liver/pathology ; Lung/pathology ; Lymph Nodes/pathology ; Lymphohistiocytosis, Hemophagocytic/diagnosis ; Lymphohistiocytosis, Hemophagocytic/pathology ; Lymphohistiocytosis, Hemophagocytic/virology ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/pathology ; SARS-CoV-2 ; Spleen/pathology
    Keywords covid19
    Language English
    Publishing date 2020-07-17
    Publishing country England
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2944-0
    ISSN 1943-7722 ; 0002-9173
    ISSN (online) 1943-7722
    ISSN 0002-9173
    DOI 10.1093/ajcp/aqaa124
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Hemophagocytic lymphohistiocytosis secondary to histoplasmosis: A case report in a patient with AIDS and recent SARS-CoV-2 infection and minireview.

    Pipitò, Luca / Medaglia, Alice Annalisa / Trizzino, Marcello / Mancuso, Alessandro / Catania, Bianca / Mancuso, Salvatrice / Calà, Cinzia / Florena, Ada Maria / Cascio, Antonio

    Heliyon

    2023  Volume 9, Issue 8, Page(s) e18537

    Abstract: ... visited Africa in the past decade. She developed a reactive hemophagocytic lymphohistiocytosis and ... area, even after many years, considering the possible reactivation of latent infection. ... compared with those of all other cases of hemophagocytic syndrome secondary to histoplasmosis in HIV ...

    Abstract Here, we describe the case of a naïve HIV late presenter female African patient with progressive disseminated histoplasmosis and a severe life-threatening clinical picture in a non-endemic area. She had not visited Africa in the past decade. She developed a reactive hemophagocytic lymphohistiocytosis and an acute psychiatric disorder. Histoplasmosis was diagnosed after two bone marrow biopsies. Therapy with liposomal amphotericin B resulted in rapid and progressive improvements in blood examinations and clinical conditions, including the disappearance of psychiatric disorders. The characteristics of our case were compared with those of all other cases of hemophagocytic syndrome secondary to histoplasmosis in HIV-positive patients reported in PubMed. In conclusion, clinicians outside endemic areas should evaluate histoplasmosis as a cause of severe clinical picture, especially in a patient with a travel history to an endemic area, even after many years, considering the possible reactivation of latent infection.
    Language English
    Publishing date 2023-07-21
    Publishing country England
    Document type Case Reports
    ZDB-ID 2835763-2
    ISSN 2405-8440
    ISSN 2405-8440
    DOI 10.1016/j.heliyon.2023.e18537
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].

    Deng, Yunxin / Lu, Shasha / Zhang, Guofang / Sun, Wenqing / Chu, Yufeng / Meng, Mei / Cui, Yunliang / Li, Pibao

    Zhonghua wei zhong bing ji jiu yi xue

    2023  Volume 35, Issue 8, Page(s) 793–799

    Abstract: ... in elderly patients with severe SARS-CoV-2 infection, and to analyze and summarize its clinical features and ... who were diagnosed with severe SARS-CoV-2 infection during their assistance to Hubei or support ... for diagnosis and treatment of SARS-CoV-2 infection in Shandong Province. The clinical data of patients were ...

    Abstract Objective: To explore the incidence of secondary hemophagocytic lymphohistiocytosis (sHLH) in elderly patients with severe SARS-CoV-2 infection, and to analyze and summarize its clinical features and risk factors for early identification of high-risk groups.
    Methods: A retrospective cohort study was conducted. From January to May 2020, No. 960 Hospital of People's Liberation Army, the Second Hospital Affiliated to Cheeloo College of Medicine of Shandong Province, the First Rehabilitation Hospital of Shandong Province, the Public Health Clinical Center Affiliated to Shandong University, and Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine received 248 patients over 60 years old who were diagnosed with severe SARS-CoV-2 infection during their assistance to Hubei or support for diagnosis and treatment of SARS-CoV-2 infection in Shandong Province. The clinical data of patients were collected. According to the hemophagocytic lymphohistiocytosis diagnosis scoring (HScore) criteria, the patients were divided into sHLH group (HScore > 169) and non-sHLH group (HScore < 98). The demographic data, clinical features, laboratory results, the proportion of organ failure and 60-day mortality of patients were collected and compared between the two groups. The risk factors of sHLH and 60-day death were evaluated through binary multivariate Logistic regression analysis in elderly patients with severe SARS-CoV-2 infection. The receiver operator characteristic curve (ROC curve) was plotted to analyze the diagnostic value of indicators only or combined for sHLH.
    Results: Among 248 elderly patients with severe SARS-CoV-2 infection, 82 patients with incomplete data and untraceable clinical outcomes, and 35 patients with HScore of 98-169 were excluded. Finally, 131 patients were enrolled in the final follow-up and statistics, including 25 patients in the sHLH group and 106 patients in the non-sHLH group. Compared with the non-sHLH group, plasma albumin (ALB), hemoglobin (Hb), lymphocyte count (LYM), platelet count (PLT), fibrinogen (Fib) and prealbumin (PAB) in the sHLH group were significantly reduced, while alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), MB isoenzyme of creatine kinase (CK-MB), serum creatinine (SCr), C-reactive protein (CRP), D-dimer, ferritin (Fer), lactate dehydrogenase (LDH), procalcitonin (PCT), cardiac troponin I (cTnI), triglycerides (TG), interleukin-6 (IL-6), total bilirubin (TBil) were significantly higher. The fever and fatigue in the sHLH group were more severe than those in the non-sHLH group, and the patients in the sHLH group had higher rates of shock, acute kidney injury, liver dysfunction, and cardiac injury than the non-sHLH group. The 60-day mortality of patient in the sHLH group was significantly higher than that in the non-sHLH group [84.0% (21/25) vs. 40.6% (43/106), P < 0.01]. Binary multivariate Logistic regression analysis showed that high Fer [odds ratio (OR) = 0.997, 95% confidence interval (95%CI) was 0.996-0.998], D-dimer (OR = 0.960, 95%CI was 0.944-0.977), LDH (OR = 0.998, 95%CI was 0.997-0.999) and TG (OR = 0.706, 95%CI was 0.579-0.860) were independent risk factors for sHLH in elderly patients with severe SARS-CoV-2 infection (all P < 0.01), while elevated Fer (OR = 1.001, 95%CI was 1.001-1.002), LDH (OR = 1.004, 95%CI was 1.002-1.005) and D-dimer (OR = 1.036, 95%CI was 1.018-1.055) were independent risk factors for 60-day death of patients (all P < 0.01). The death risk of the sHLH patients was 7.692 times higher than that of the non-sHLH patients (OR = 7.692, 95%CI was 2.466-23.987, P = 0.000). ROC curve analysis showed that a three-composite-index composed of LDH, D-dimer and TG had good diagnostic value for sHLH in elderly patients with severe SARS-CoV-2 infection [area under the ROC curve (AUC) = 0.920, 95%CI was 0.866-0.973, P = 0.000].
    Conclusions: Elderly patients with severe SARS-CoV-2 infection complicated by sHLH tend to be critically ill and have refractory status and worse prognosis. High Fer, LDH, D-dimer and TG are independent risk factors for sHLH, and are highly suggestive of poor outcome. The comprehensive index composed of LDH, D-dimer and TG has good diagnostic value, and can be used as an early screening tool for sHLH in elderly patients with severe SARS-CoV-2 infection.
    MeSH term(s) Aged ; Humans ; Middle Aged ; Lymphohistiocytosis, Hemophagocytic/diagnosis ; Retrospective Studies ; COVID-19/complications ; SARS-CoV-2 ; China/epidemiology ; Risk Factors
    Language Chinese
    Publishing date 2023-06-13
    Publishing country China
    Document type Multicenter Study ; English Abstract ; Journal Article
    ISSN 2095-4352
    ISSN 2095-4352
    DOI 10.3760/cma.j.cn121430-20230510-00158
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis

    Prilutskiy, Andrey / Kritselis, Michael / Shevtsov, Artem / Yambayev, Ilyas / Vadlamudi, Charitha / Zhao, Qing / Kataria, Yachana / Sarosiek, Shayna R / Lerner, Adam / Sloan, J Mark / Quillen, Karen / Burks, Eric J

    Am J Clin Pathol

    Abstract: ... of cytokine storm. However, clinicopathologic features diagnostic of hemophagocytic lymphohistiocytosis (HLH ... score of 145 due to a missing triglyceride level. The remaining 2 patients had H-scores of 131 and 96 ... CONCLUSIONS: This is the first report of severe acute respiratory syndrome coronavirus 2-associated HLH ...

    Abstract OBJECTIVES: A subset of coronavirus disease 2019 (COVID-19) patients exhibit clinical features of cytokine storm. However, clinicopathologic features diagnostic of hemophagocytic lymphohistiocytosis (HLH) have not been reported. We studied the reticuloendothelial organs of 4 consecutive patients who died of COVID-19 and correlated with clinical and laboratory parameters to detect HLH. METHODS: Autopsies were performed on 4 patients who died of COVID-19. Routine H&E staining and immunohistochemical staining for CD163 were performed to detect hemophagocytosis. Clinical and laboratory results from premortem blood samples were used to calculate H-scores. RESULTS: All 4 cases demonstrated diffuse alveolar damage within the lungs. Three of the 4 cases had histologic evidence of hemophagocytosis within pulmonary lymph nodes. One case showed hemophagocytosis in the spleen but none showed hemophagocytosis in liver or bone marrow. Lymphophagocytosis was the predominant form of hemophagocytosis observed. One patient showed diagnostic features of HLH with an H-score of 217, while a second patient likely had HLH with a partial H-score of 145 due to a missing triglyceride level. The remaining 2 patients had H-scores of 131 and 96. CONCLUSIONS: This is the first report of severe acute respiratory syndrome coronavirus 2-associated HLH. Identification of HLH in a subset of patients with severe COVID-19 will inform clinical trials of therapeutic strategies.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #654222
    Database COVID19

    Kategorien

  9. Article ; Online: Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination.

    Hieber, Marie-Lisa / Sprute, Rosanne / Eichenauer, Dennis A / Hallek, Michael / Jachimowicz, Ron D

    Infection

    2022  Volume 50, Issue 5, Page(s) 1399–1404

    Abstract: ... Methods: We report a case of severe hemophagocytic lymphohistiocytosis (HLH) after SARS-CoV-2 ... after SARS-CoV-2 vaccination, the majority after immunization with Comirnaty (n = 7) or the viral vector ... n = 5), and etoposide (n = 2). Eight patients underwent combination treatment. Three of 16 patients ...

    Abstract Purpose: The coronavirus disease 2019 (COVID-19) pandemic has led to the approval of novel vaccines with different mechanisms of action. Until now, more than 4.7 billion persons have been vaccinated around the world, and adverse effects not observed in pre-authorization trials are being reported at low frequency.
    Methods: We report a case of severe hemophagocytic lymphohistiocytosis (HLH) after SARS-CoV-2 immunization and performed a literature search for all reported cases of COVID-19 vaccine-associated HLH.
    Results: A 24-year-old female developed HLH after immunization with the mRNA COVID-19 vaccine Comirnaty. Diagnosis was made according to HLH-2004 criteria; the HScore was 259 (> 99% HLH probability) with maximum ferritin of 138.244 µg/L. The patient was initially treated with intravenous immunoglobulins (IVIGs) and dexamethasone without response. The addition of the human interleukin 1 receptor antagonist Anakinra resulted in full recovery within 6 weeks after vaccination. A literature search revealed 15 additional cases of HLH after SARS-CoV-2 vaccination, the majority after immunization with Comirnaty (n = 7) or the viral vector vaccine Vaxzevria (n = 6). Treatment modalities included corticosteroids (n = 13), Anakinra (n = 5), IVIGs (n = 5), and etoposide (n = 2). Eight patients underwent combination treatment. Three of 16 patients died.
    Conclusion: COVID-19 vaccines may occasionally trigger HLH, and Anakinra may be an efficacious treatment option for this condition.
    MeSH term(s) Adrenal Cortex Hormones ; Adult ; COVID-19/prevention & control ; COVID-19 Vaccines/adverse effects ; Dexamethasone/therapeutic use ; Etoposide ; Female ; Ferritins ; Humans ; Immunoglobulins, Intravenous ; Interleukin 1 Receptor Antagonist Protein ; Lymphohistiocytosis, Hemophagocytic/diagnosis ; Lymphohistiocytosis, Hemophagocytic/drug therapy ; Lymphohistiocytosis, Hemophagocytic/etiology ; RNA, Messenger ; Receptors, Interleukin-1 ; SARS-CoV-2 ; Vaccination ; Young Adult
    Chemical Substances Adrenal Cortex Hormones ; COVID-19 Vaccines ; Immunoglobulins, Intravenous ; Interleukin 1 Receptor Antagonist Protein ; RNA, Messenger ; Receptors, Interleukin-1 ; Etoposide (6PLQ3CP4P3) ; Dexamethasone (7S5I7G3JQL) ; Ferritins (9007-73-2)
    Language English
    Publishing date 2022-02-26
    Publishing country Germany
    Document type Case Reports ; Journal Article
    ZDB-ID 185104-4
    ISSN 1439-0973 ; 0300-8126 ; 0173-2129
    ISSN (online) 1439-0973
    ISSN 0300-8126 ; 0173-2129
    DOI 10.1007/s15010-022-01786-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top